16:02 Dec 20
Gufic BioSciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Gufic BioSciences Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
18/100
Low Financial Strength
Valuation
25/100
Expensive Valuation
Technical
66/100
Technically Moderately Bullish
Strength
4
Weakness
4
Opportunity
1
Threats
0
16.17 %
ROE %
7.88 %
ROA %
8.47
EPS
53.11
BVPS
10.67 %
Net Profit Margin
| Mar 2024 | TTM 2024 | ||
|---|---|---|---|
| Net Sales | 806.67 | 803.76 | |
| Operating Expenses + | 660.79 | 658.67 | |
| Raw Material | 389.32 | 366.93 | |
| Increase Decrease in Cost | 0.57 | 7.88 | |
| Other Manufacturing Expense | 0 | 0 | |
| Employee Cost | 109.63 | 117.72 | |
| Miscellaneous Expenses | 277.39 | 166.14 | |
| Operating Profit | 145.88 | 145.09 | |
| Other Income | 2.18 | 2.66 | |
| Depreciation | 17.02 | 17.09 | |
| Interest | 15.36 | 16.63 | |
| Profit before tax and exceptio.. | 115.67 | 114.03 | |
| Exceptional Items | 0 | 0 | |
| PBT | 115.67 | 114.03 | |
| Provision for Taxation | 29.54 | 29.11 | |
| Net Profit | 86.14 | 84.94 | |
| NET Profit after MI | 86.14 | 84.94 | |
| EPS | 8.74 | 8.48 | |
| Operating Profit Margin (%) | 18.08 | 18.05 | |
| Net Profit Margin (%) | 10.68 | 10.57 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Promoter | 72.50 | 72.50 | 72.50 | 72.50 | 75.00 |
| FII | 0.20 | 0.20 | 0.10 | 0.50 | 0.70 |
| MF | 2.50 | 2.30 | 2.10 | 1.60 | 1.50 |
| Public | 24.80 | 24.90 | 25.20 | 25.30 | 22.60 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Others | 0.00 | 0.10 | 0.10 | 0.10 | 0.20 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
